Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

What's in a name? Generic vs brand name drugs.

Levin AA.

Health PAC Bull. 1986 Jun;16(5):37, 39. No abstract available.

PMID:
10276741
2.

Generic vs. brand name drugs--quality, not cost, is key issue.

Stetler CJ.

Internist. 1979 May;20(4):9-10, 12. No abstract available.

PMID:
10242133
3.
4.

Comparing brand name drugs to their generic equivalents.

DeDea L.

JAAPA. 2011 Jun;24(6):19. No abstract available.

PMID:
21682170
5.

Generic vs. brand name drugs--defining and enforcing standards.

Lasagna LC.

Internist. 1979 May;20(4):11, 13. No abstract available.

PMID:
10316827
6.

Status of generic substitution: problematic drug classes reviewed.

Ross MB.

Hosp Formul. 1989 Aug;24(8):441-4, 447-9.

PMID:
10294356
7.

Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle.

Felch WC.

Internist. 1979 May;20(4):3-5. No abstract available.

PMID:
10242131
8.

Information that brand-name companies do not tell us.

Marcoux AW.

Drug Intell Clin Pharm. 1987 Mar;21(3):296-7. No abstract available.

PMID:
3569035
9.

What's in a name? Generics and the persistence of the pharmaceutical brand in American medicine.

Greene JA.

J Hist Med Allied Sci. 2011 Oct;66(4):468-506. doi: 10.1093/jhmas/jrq049. Epub 2010 Sep 21.

PMID:
20858701
10.

Generic and alternative brand-name pharmaceutical equivalents: select with caution.

Hendeles L, Hochhaus G, Kazerounian S.

Am J Hosp Pharm. 1993 Feb;50(2):323-9. Review. No abstract available. Erratum in: Am J Hosp Pharm 1993 May;50(5):913.

PMID:
8480793
11.

Buy some today: can generics be safely substituted for brand-name drugs?

Lesser RP, Krauss G.

Neurology. 2001 Aug 28;57(4):571-3. No abstract available.

PMID:
11524462
12.

Equivalence of generic and brand-name ophthalmic products.

Fiscella RG, Gaynes BI, Jensen M.

Am J Health Syst Pharm. 2001 Apr 1;58(7):616-7. No abstract available.

PMID:
11296613
13.
14.

Branded drug reformulation: the next brand vs. generic antitrust battleground.

Amoresano GV.

Food Drug Law J. 2007;62(1):249-56. No abstract available.

PMID:
17444032
15.

Generic versus brand name psychotropics.

Ayd FJ Jr.

Am J Psychiatry. 1978 Nov;135(11):1428. No abstract available.

PMID:
707658
16.

Generics still a favorite Rx for savings.

Wagner M.

Mod Healthc. 1990 May 28;20(21):26-8, 30, 32-3.

PMID:
10104890
17.

FDA drug list: key to generic substitution.

[No authors listed]

FDA Consum. 1979 Feb;13(1):15-7.

PMID:
10308816
18.

What's the problem with generic antiepileptic drugs?: a call to action.

Berg MJ.

Neurology. 2007 Apr 17;68(16):1245-6. No abstract available.

PMID:
17438211
19.

Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.

Heller WM.

Am J Hosp Pharm. 1993 Feb;50(2):318-22. Review. No abstract available.

PMID:
8480792
20.

DPS--the PMA perspective.

Beary JF 3rd, Cleveland CB.

Am Pharm. 1992 May;NS32(5):6, 8. No abstract available.

PMID:
1590210

Supplemental Content

Support Center